Endomagnetics wins first ever ETPN Nanomedicine Award
6 November 2013
Cambridge-based Endomagnetics has been named as one of two
winners of the inaugural Nanomedicine Award for its cancer
The Nanomedicine Award winners were announced during the
Nanomedicine Panel Session at BIO-Europe 2013 in Vienna this week.
Launched in June 2013, the Nanomedicine Award has been organised
by the European Technology Platform for Nanomedicine (ETPN),
together with the EU funded consortium NANOMED2020, to honour the
best international nanomedicine innovations. Academia and industry
alike were eligible for the first award which covered the fields of
diagnostics and imaging, therapeutics and regenerative medicine.
“A global consensus was reached to deliver the award to
Endomagnetics for its outstanding development,” said a spokesperson
for the Award Review Board, which consists of a panel of respected
pharma industry specialists. The Board commented on the concrete
potential and promise of nanomedicine.
“Endomagnetics is very honoured to have been selected for an
inaugural Nanomedicine Award, particularly given the global
candidature and great promise of this convergent industry”, said CEO
of Endomagnetics Dr Eric Mayes. “This award enhances the medtech
facet of nanomedicine and increases the visibility of our SentiMag
and Sienna+ system to potential partners as we develop further
across the nanomedicine field.”
As a winner, Endomagnetics made a presentation at the
Nanomedicine Panel Discussion during the awards event. In addition,
the company will also present during the CLINAM conference 2014 in
Last month, Endomagnetics was announced as a finalist in the IET
Innovation Awards to be judged on 20th November.